A leading Australian-American sleep apnoea machine maker is predicting additional tailwinds from big tech after delivering another set of strong quarterly earnings.
ResMed generated revenue of $US1.4 billion ($A2 billion) in the first quarter, which was up six per cent from a year ago and ahead of consensus expectations, while earnings per share rose 14 per cent.